Compile Data Set for Download or QSAR
maximum 50k data
Found 264 with Last Name = 'nabakka' and Initial = 'j'
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193944(US9199981, F35)
Affinity DataIC50:  3nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeptide deformylase(Staphylococcus aureus (strain Mu50 / ATCC 700699))
Genomics Institute Of The Novartis Research Foundation

Curated by ChEMBL
LigandPNGBDBM50224043(CHEMBL36229)
Affinity DataIC50: <5nMAssay Description:Inhibitory activity towards Ni-peptide deformylase of Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeptide deformylase(Staphylococcus aureus (strain Mu50 / ATCC 700699))
Genomics Institute Of The Novartis Research Foundation

Curated by ChEMBL
LigandPNGBDBM50141373(CHEMBL37719 | N-Hydroxy-2-(3-oxo-3,4-dihydro-2H-be...)
Affinity DataIC50: <5nMAssay Description:Inhibitory activity towards Ni-peptide deformylase of Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeptide deformylase(Staphylococcus aureus (strain Mu50 / ATCC 700699))
Genomics Institute Of The Novartis Research Foundation

Curated by ChEMBL
LigandPNGBDBM50224039(CHEMBL36605)
Affinity DataIC50: <5nMAssay Description:Inhibitory activity towards Ni-peptide deformylase of Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeptide deformylase(Staphylococcus aureus (strain Mu50 / ATCC 700699))
Genomics Institute Of The Novartis Research Foundation

Curated by ChEMBL
LigandPNGBDBM50224042(CHEMBL36140)
Affinity DataIC50: <5nMAssay Description:Inhibitory activity towards Ni-peptide deformylase of Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeptide deformylase(Staphylococcus aureus (strain Mu50 / ATCC 700699))
Genomics Institute Of The Novartis Research Foundation

Curated by ChEMBL
LigandPNGBDBM50224038(CHEMBL38016)
Affinity DataIC50: <5nMAssay Description:Inhibitory activity towards Ni-peptide deformylase of Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeptide deformylase(Staphylococcus aureus (strain Mu50 / ATCC 700699))
Genomics Institute Of The Novartis Research Foundation

Curated by ChEMBL
LigandPNGBDBM50224041(CHEMBL34538)
Affinity DataIC50: <5nMAssay Description:Inhibitory activity towards Ni-peptide deformylase of Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPeptide deformylase(Staphylococcus aureus (strain Mu50 / ATCC 700699))
Genomics Institute Of The Novartis Research Foundation

Curated by ChEMBL
LigandPNGBDBM50089194((R)-N*4*-Hydroxy-N*1*-[(S)-1-((S)-2-hydroxymethyl-...)
Affinity DataIC50: <5nMAssay Description:Inhibitory activity towards Ni-peptide deformylase of Staphylococcus aureusMore data for this Ligand-Target Pair
TargetPeptide deformylase(Staphylococcus aureus (strain Mu50 / ATCC 700699))
Genomics Institute Of The Novartis Research Foundation

Curated by ChEMBL
LigandPNGBDBM50224040(CHEMBL286441)
Affinity DataIC50: <5nMAssay Description:Inhibitory activity towards Ni-peptide deformylase of Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193953(US9199981, F44)
Affinity DataIC50:  6nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193968(US9199981, F59)
Affinity DataIC50:  7nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193951(US9199981, F42)
Affinity DataIC50:  7nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193923(US9199981, F13 | US9199981, F92)
Affinity DataIC50:  7nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193949(US9199981, F40)
Affinity DataIC50:  9nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM194009(US9199981, F102)
Affinity DataIC50:  9nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM194084(US9199981, F19)
Affinity DataIC50:  9nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193987(US9199981, F78)
Affinity DataIC50:  10nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeptide deformylase(Staphylococcus aureus (strain Mu50 / ATCC 700699))
Genomics Institute Of The Novartis Research Foundation

Curated by ChEMBL
LigandPNGBDBM50141359(CHEMBL285938 | N-Hydroxy-N-(3-oxo-3,4-dihydro-2H-b...)
Affinity DataIC50:  10nMAssay Description:Inhibitory activity towards Ni-peptide deformylase of Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193950(US9199981, F41)
Affinity DataIC50:  11nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193924(US9199981, F14)
Affinity DataIC50:  12nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeptide deformylase(Staphylococcus aureus (strain Mu50 / ATCC 700699))
Genomics Institute Of The Novartis Research Foundation

Curated by ChEMBL
LigandPNGBDBM50141360(2-(4-Benzyl-3-oxo-3,4-dihydro-2H-benzo[1,4]thiazin...)
Affinity DataIC50:  12nMAssay Description:Inhibitory activity towards Ni-peptide deformylase of Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193922(US9199981, F12)
Affinity DataIC50:  12nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193952(US9199981, F43)
Affinity DataIC50:  12nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193934(US9199981, F25)
Affinity DataIC50:  13nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193974(US9199981, F65)
Affinity DataIC50:  13nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193955(US9199981, F46)
Affinity DataIC50:  13nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193917(US9199981, F7)
Affinity DataIC50:  15nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM194010(US9199981, F103)
Affinity DataIC50:  16nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193939(US9199981, F30)
Affinity DataIC50:  16nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193943(US9199981, F34)
Affinity DataIC50:  16nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193957(US9199981, F48)
Affinity DataIC50:  16nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193975(US9199981, F66)
Affinity DataIC50:  16nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193984(US9199981, F75)
Affinity DataIC50:  17nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPeptide deformylase(Staphylococcus aureus (strain Mu50 / ATCC 700699))
Genomics Institute Of The Novartis Research Foundation

Curated by ChEMBL
LigandPNGBDBM50141370(CHEMBL34024 | N-Hydroxy-2-[3-oxo-4-(tetrahydro-pyr...)
Affinity DataIC50:  18nMAssay Description:Inhibitory activity towards Ni-peptide deformylase of Staphylococcus aureusMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193978(US9199981, F69 | US9199981, F80)
Affinity DataIC50:  19nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193978(US9199981, F69 | US9199981, F80)
Affinity DataIC50:  20nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193967(US9199981, F58)
Affinity DataIC50:  20nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193999(US9199981, F110 | US9199981, F91)
Affinity DataIC50:  20nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193914(US9199981, F4)
Affinity DataIC50:  22nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193992(US9199981, F84)
Affinity DataIC50:  22nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193966(US9199981, F57)
Affinity DataIC50:  23nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetOxysterols receptor LXR-beta(Homo sapiens (Human))
Gnf

LigandPNGBDBM19992(2-[3-[3-[[2-chloro-3-(trifluoromethyl)phenyl]methy...)
Affinity DataIC50:  23nMAssay Description:SPA assays were run in displacement mode using 30 nM [3H]-GW3965. Ligands were tested in 12-point dose-response curves starting at 20 uM. IC50 values...More data for this Ligand-Target Pair
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM194000(US9199981, F93)
Affinity DataIC50:  24nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193915(US9199981, F5)
Affinity DataIC50:  24nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193911(US9199981, F1)
Affinity DataIC50:  24nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193997(US9199981, F89)
Affinity DataIC50:  25nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193947(US9199981, F38)
Affinity DataIC50:  25nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193941(US9199981, F32)
Affinity DataIC50:  25nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193928(US9199981, F18)
Affinity DataIC50:  25nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetMast/stem cell growth factor receptor Kit(Homo sapiens (Human))
Novartis

US Patent
LigandPNGBDBM193979(US9199981, F70)
Affinity DataIC50:  26nMAssay Description:The compounds was tested for inhibition of SCF dependent proliferation using human Mo7e cells which endogenously express c-kit in a 384 well format. ...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 264 total ) | Next | Last >>
Jump to: